This trial will test if 4 weeks of sympathetic nerve activity inhibition can reduce circulating blood concentrations and expression of inflammatory markers.
3 Primary · 0 Secondary · Reporting Duration: 4 Week
Experimental Treatment
Non-Treatment Group
60 Total Participants · 3 Treatment Groups
Primary Treatment: Clonidine Pill · Has Placebo Group · Phase 1
Age 18 - 79 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Missouri | 66.7% |
Kansas | 33.3% |
18 - 65 | 66.7% |
65+ | 33.3% |
University of Kansas Medical Center | 100.0% |
Met criteria | 66.7% |
Did not meet criteria | 33.3% |